Brought to you by 
Within the pharmaceutical industry, artificial intelligence (AI) is propelling innovation and process enhancement, as evidenced by the upsurge in AI-related patents. Strategic collaborations and evolving hiring patterns further highlight AI’s transformative impact on the industry. With a reach extending beyond the pharmaceutical domain, AI’s influence is felt across diverse industries. GlobalData’s artificial intelligence (AI) market report helps keep abreast of the latest trends in AI, market opportunity forecast and the competitive landscape. Buy the report here.
Within the pharmaceutical industry, artificial intelligence (AI) is propelling innovation and process enhancement, as evidenced by the upsurge in AI-related patents. Strategic collaborations and evolving hiring patterns further highlight AI’s transformative impact on the industry. With a reach extending beyond the pharmaceutical domain, AI’s influence is felt across diverse industries. GlobalData’s artificial intelligence (AI) market report helps keep abreast of the latest trends in AI, market opportunity forecast and the competitive landscape. Buy the report here.
Buy the Report
This article presents a quarterly round-up of the latest trends in the pharmaceutical industry regarding AI. It provides an overview of recent developments in AI-related deals, talent acquisition, and patent filings within the pharmaceutical industry.
Diverse applications of artificial intelligence in pharmaceutical industry
Pharma companies are leveraging artificial intelligence (AI) technologies to innovate and improve their businesses, as evidenced by the latest patents in the field. One such patent is for a networked cell culture incubator that utilizes parameter data from other incubators to create an improved environment for cell culture growth. This technology, developed by Thrive Bioscience Inc, allows for the sharing of parameter data between incubators, enhancing the efficiency and effectiveness of cell culture processes.
Another patent focuses on a low intensity vibration system for bioprocessing, developed by The Research Foundation for the State University of New York. This system utilizes orthogonal acceleration signals to transmit forces to a stage, enabling more precise and controlled bioprocessing.
Children’s Medical Center has obtained patents for adjuvants used in Betacoronavirus vaccines and thiazole amide compounds for modulating human immune response. These innovations have the potential to enhance immune responses and improve the efficacy of vaccines in treating and preventing diseases.
Lastly, Sophie’s BioNutrients Pte Ltd has developed an AI simulation method for microalgae fermentation. This technology allows users to input specific parameters and simulate the fermentation process, providing valuable insights and optimizing the production of microalgae.
Overall, these patents highlight the advancements in AI technologies and applications within the pharmaceutical industry. By leveraging these innovations, pharma companies can improve their processes, enhance immune responses, and optimize the production of valuable substances like microalgae.
The industry experienced a 40% growth in the number of AI-related patent applications in Q2 2023 compared with the previous quarter. On an annual basis, the number of AI-related patent applications in the pharmaceutical industry witnessed a rise of 85% compared with Q2 2022.
Strategic deal trends in artificial intelligence in pharmaceutical industry
Pharmaceutical companies are not only focusing on innovation to enhance their patent portfolios but are also making strategic investments in AI. These investments aim to secure lucrative deals with partners and position themselves at the forefront of industry advancements. Some of the recent deals underscore the importance of AI in the pharmaceutical industry.
In Q2 2023, the number of AI-related deals in the pharmaceutical industry grew by 41% compared with Q2 2022. On a quarterly basis, there was 15% drop in the number of deals in Q2 2023 compared with the previous quarter.
Impact on hiring
In terms of new job posting, in Q2 2023, the pharmaceutical industry experienced a 24% growth compared with the previous quarter. On an annual basis, job postings also grew by 16%. Notably, management occupations, with a share of 23%, emerged as the top AI-related job roles within the pharmaceutical industry in Q2 2023, with new job postings rising by 5% quarter-on-quarter. Computer and mathematical occupations came in second with a share of 19% in Q2 2023, with new job postings dropping by 8% over the previous quarter. The other prominent AI roles include Life, physical, and social science occupations with a 9% share in Q2 2023, and business and financial operations occupations with a 3% share of new job postings.
Johnson & Johnson, Novartis, Novo Nordisk, AstraZeneca, and Sanofi are among the top companies leading in AI hiring within the pharmaceutical industry.
Countries driving adoption of artificial intelligence in pharmaceutical industry
The US is the leading country in AI adoption within the pharmaceutical industry, boasting the highest number of AI-related patents, jobs, and deals. Meanwhile, China, South Korea, the UK and India also maintain significant positions in AI adoption within the pharmaceutical industry.
In conclusion, AI’s presence in the pharmaceutical sector is underscored by the notable increase in patent applications, indicative of the industry’s commitment to innovation. Strategic deals highlight the significant role AI investments play in fostering partnerships and industry advancements. Additionally, evolving hiring patterns point to a rising demand for AI-related roles within the pharmaceutical domain.
To further understand GlobalData’s analysis on artificial intelligence in the pharmaceutical industry, buy the report here.
Give your business an edge with our leading industry insights.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData patent analytics tracks patent filings and grants across companies and themes. Proprietary databases on deals and job analytics are used to respectively monitor global deal activity and uncover insights from daily job postings to identify trends, company activities, and industry dynamics across different sectors globally.
Buy the Report
Give your business an edge with our leading industry insights.
Give your business an edge with our leading industry insights.
I consent to Verdict Media Limited collecting my details provided via this form in accordance with Privacy Policy
View all newsletters from across the GlobalData Media network.
The leading site for news and procurement in the pharmaceutical industry
Powered by 
© Verdict Media Limited 2023
Leave a Reply
You must be logged in to post a comment.